Cargando…

A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea

More than 50% of the world’s lung cancer cases occur in Asia and more than 20% of cancer deaths in Asia are attributable to lung cancer. The U.S. National Lung Screening Trial has shown that lung cancer screening with computed tomography (CT) can reduce lung cancer deaths. Using the Lung Cancer Poli...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yufan, Watson, Tina R., Criss, Steven D., Eckel, Andrew, Palazzo, Lauren, Sheehan, Deirdre F., Kong, Chung Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667161/
https://www.ncbi.nlm.nih.gov/pubmed/31361789
http://dx.doi.org/10.1371/journal.pone.0220610
_version_ 1783440008675328000
author Chen, Yufan
Watson, Tina R.
Criss, Steven D.
Eckel, Andrew
Palazzo, Lauren
Sheehan, Deirdre F.
Kong, Chung Yin
author_facet Chen, Yufan
Watson, Tina R.
Criss, Steven D.
Eckel, Andrew
Palazzo, Lauren
Sheehan, Deirdre F.
Kong, Chung Yin
author_sort Chen, Yufan
collection PubMed
description More than 50% of the world’s lung cancer cases occur in Asia and more than 20% of cancer deaths in Asia are attributable to lung cancer. The U.S. National Lung Screening Trial has shown that lung cancer screening with computed tomography (CT) can reduce lung cancer deaths. Using the Lung Cancer Policy Model–Asia (LCPM-Asia), we estimated the potential mortality reduction achievable through the implementation of CT-based lung cancer screening in China, Japan, Singapore, and South Korea. The LCPM-Asia was calibrated to the smoking prevalence of each of the aforementioned countries based on published national surveys and to lung cancer mortality rates from the World Health Organization. The calibrated LCPM-Asia was then used to simulate lung cancer deaths under screening and no-screening scenarios for the four countries. Using screening eligibility criteria recommended by the U.S. Centers for Medicare & Medicaid Services (CMS), which are based on age and smoking history, we estimated the lung cancer mortality reduction from screening through year 2040. By 2040, lung cancer screening would result in 91,362 life-years gained and 4.74% mortality reduction in South Korea; 290,325 life-years gained and 4.33% mortality reduction in Japan; 3,014,215 life-years gained and 4.22% mortality reduction in China; and 8,118 life-years gained and 3.76% mortality reduction in Singapore. As for mortality reduction by smoker type, current smokers would have the greatest mortality reduction in each country, ranging from 5.56% in Japan to 6.86% in Singapore. Among the four countries, lung cancer screening under CMS eligibility criteria was most effective in South Korea and least effective in Singapore. Singapore’s low smoking prevalence and South Korea’s aging population and higher smoking prevalence may partially explain the discrepancy in effectiveness. CT screening was shown to be promising as a means of reducing lung cancer mortality in the four countries.
format Online
Article
Text
id pubmed-6667161
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-66671612019-08-07 A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea Chen, Yufan Watson, Tina R. Criss, Steven D. Eckel, Andrew Palazzo, Lauren Sheehan, Deirdre F. Kong, Chung Yin PLoS One Research Article More than 50% of the world’s lung cancer cases occur in Asia and more than 20% of cancer deaths in Asia are attributable to lung cancer. The U.S. National Lung Screening Trial has shown that lung cancer screening with computed tomography (CT) can reduce lung cancer deaths. Using the Lung Cancer Policy Model–Asia (LCPM-Asia), we estimated the potential mortality reduction achievable through the implementation of CT-based lung cancer screening in China, Japan, Singapore, and South Korea. The LCPM-Asia was calibrated to the smoking prevalence of each of the aforementioned countries based on published national surveys and to lung cancer mortality rates from the World Health Organization. The calibrated LCPM-Asia was then used to simulate lung cancer deaths under screening and no-screening scenarios for the four countries. Using screening eligibility criteria recommended by the U.S. Centers for Medicare & Medicaid Services (CMS), which are based on age and smoking history, we estimated the lung cancer mortality reduction from screening through year 2040. By 2040, lung cancer screening would result in 91,362 life-years gained and 4.74% mortality reduction in South Korea; 290,325 life-years gained and 4.33% mortality reduction in Japan; 3,014,215 life-years gained and 4.22% mortality reduction in China; and 8,118 life-years gained and 3.76% mortality reduction in Singapore. As for mortality reduction by smoker type, current smokers would have the greatest mortality reduction in each country, ranging from 5.56% in Japan to 6.86% in Singapore. Among the four countries, lung cancer screening under CMS eligibility criteria was most effective in South Korea and least effective in Singapore. Singapore’s low smoking prevalence and South Korea’s aging population and higher smoking prevalence may partially explain the discrepancy in effectiveness. CT screening was shown to be promising as a means of reducing lung cancer mortality in the four countries. Public Library of Science 2019-07-30 /pmc/articles/PMC6667161/ /pubmed/31361789 http://dx.doi.org/10.1371/journal.pone.0220610 Text en © 2019 Chen et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Chen, Yufan
Watson, Tina R.
Criss, Steven D.
Eckel, Andrew
Palazzo, Lauren
Sheehan, Deirdre F.
Kong, Chung Yin
A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea
title A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea
title_full A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea
title_fullStr A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea
title_full_unstemmed A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea
title_short A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea
title_sort simulation study of the effect of lung cancer screening in china, japan, singapore, and south korea
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667161/
https://www.ncbi.nlm.nih.gov/pubmed/31361789
http://dx.doi.org/10.1371/journal.pone.0220610
work_keys_str_mv AT chenyufan asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT watsontinar asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT crissstevend asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT eckelandrew asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT palazzolauren asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT sheehandeirdref asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT kongchungyin asimulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT chenyufan simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT watsontinar simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT crissstevend simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT eckelandrew simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT palazzolauren simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT sheehandeirdref simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea
AT kongchungyin simulationstudyoftheeffectoflungcancerscreeninginchinajapansingaporeandsouthkorea